RBC Life Sciences, Inc., a prominent player in the biotechnology and life sciences sector, is headquartered in the United States. Founded in 1997, the company has established itself as a leader in the development and distribution of innovative health products, particularly in the fields of nutritional supplements and diagnostic testing. With a focus on enhancing health and wellness, RBC Life Sciences offers a unique range of core products, including proprietary formulations that cater to various health needs. The company’s commitment to quality and scientific research has positioned it favourably in the competitive life sciences market. Notable achievements include significant advancements in product efficacy and a growing presence in key operational regions across North America.
How does RBC Life Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
RBC Life Sciences, Inc.'s score of 29 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RBC Life Sciences, Inc., headquartered in the US, currently does not report any specific carbon emissions data. However, the company has established significant climate commitments aimed at reducing its carbon footprint. RBC Life Sciences has set ambitious near-term reduction targets, aiming for a 36% reduction in absolute emissions for both Scope 1 and Scope 2 by 2030, compared to 2020 levels. This aligns with broader targets set by developed economies, including the EU and the US. In addition to these near-term goals, the company has also committed to long-term net-zero targets for Scope 1 and Scope 2 emissions, with a timeframe extending to 2060. This commitment reflects a growing trend among companies to align with global climate initiatives and the targets set by emerging economies in the region. While specific emissions data is not available, RBC Life Sciences' proactive approach to climate commitments demonstrates its dedication to sustainability and reducing its environmental impact.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
RBC Life Sciences, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

